Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope

被引:105
作者
Brignole, Michele
Sutton, Richard
Menozzi, Carlo
Garcia-Civera, Roberto
Moya, Angel
Wieling, Wouter
Andresen, Dietrich
Benditt, David G.
Grovale, Nicoletta
De Santo, Tiziana
Vardas, Panos
机构
[1] Osped Tigullio, Dept Cardiol, Arrhythmol Ctr, I-16033 Lavagna, Italy
[2] Royal Brompton Hosp, Dept Cardiol, London SW3 6LY, England
[3] Harefield Hosp, Dept Cardiol, London SW3 6LY, England
[4] Osped S Maria Nuova, Dept Cardiol, Reggio Emilia, Italy
[5] Hosp Clin, Dept Cardiol, Valencia, Spain
[6] Hosp Gen Valle Hebron, Dept Cardiol, Barcelona, Spain
[7] Acad Med Ctr, Dept Internal Med, Amsterdam, Netherlands
[8] Krankenhaus Urban, Dept Cardiol, Berlin, Germany
[9] Univ Minnesota, Dept Cardiol, Minneapolis, MN 55455 USA
[10] Medtron Italia, Clin & New Business Dev Div, Rome, Italy
[11] Univ Hosp Crete, Dept Cardiol, Iraklion, Greece
关键词
syncope; diagnosis; electrocardiographic monitoring; tilt testing; ATP test; IMPLANTABLE LOOP RECORDER; VASOVAGAL SYNCOPE; MANAGEMENT DIAGNOSIS; MONITORING STRATEGY; TRIAL; THERAPY; CLASSIFICATION; MULTICENTER; PREVENTION; GUIDELINES;
D O I
10.1093/eurheartj/ehl164
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims We prospectively correlated the results of tilt testing (TT) and adenosine triphosphate test (ATP) with the findings observed during a spontaneous syncopal relapse by means of an implantable loop recorder (ILR) in patients with a clinical diagnosis of neurally mediated syncope. Methods and results We included patients with three or more clinically severe syncopal episodes in the last 2 years without significant electrocardiographic and cardiac abnormalities. Patients with orthostatic hypotension and carotid sinus syncope were excluded. After ILR implantation, patients were followed until the first documented syncope. Among 392 enrolled patients, 343 underwent TT, which was positive in 164 (48%), and 180 ATP test, which was positive in 53 (29%). Syncope was documented by ILR in 106 (26%) patients after a median of 3 months. Patients with positive and negative TT had similar baseline characteristics, syncopal recurrence rate, and mechanism of syncope, but those with positive TT had more frequently no or slight rhythm variations during spontaneous syncope (45 vs. 21%, P=0.02). An asystolic pause was more frequently found during spontaneous syncope than during TT (45 vs. 21%, P=0.02), but there was a trend for those with an asystolic response during TT also to have an asystolic response during spontaneous syncope (75 vs. 37%, P=0.1). Patients with positive ATP test responses showed syncopal recurrence rates and mechanism of syncope similar to those with negative ATP tests. Conclusion In patients with neurally mediated syncope, clinical characteristics, outcome, and mechanism of syncope are poorly correlated and not predicted by the results of TT and ATP test. Therefore, these tests are of little or no value in guiding specific therapy.
引用
收藏
页码:2232 / 2239
页数:8
相关论文
共 23 条
[1]   Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope - A multicenter, randomized, controlled trial [J].
Ammirati, F ;
Colivicchi, F ;
Santini, M .
CIRCULATION, 2001, 104 (01) :52-57
[2]   Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope [J].
Brignole, M ;
Sutton, R ;
Menozzi, C ;
Garcia-Civera, R ;
Moya, A ;
Wieling, W ;
Andresen, D ;
Benditt, DG ;
Vardas, P .
EUROPEAN HEART JOURNAL, 2006, 27 (09) :1085-1092
[3]   Guidelines on management (diagnosis and treatment) of syncope - Update 2004 [J].
Brignole, M ;
Alboni, P ;
Benditt, DG ;
Bergfeldt, L ;
Blanc, JJ ;
Thomsen, PEB ;
van Dijk, JG ;
Fitzpatrick, A ;
Hohnloser, S ;
Janousek, J ;
Kapoor, W ;
Kenny, RA ;
Kulakowski, P ;
Masotti, G ;
Moya, A ;
Raviele, A ;
Sutton, R ;
Theodorakis, G ;
Ungar, A ;
Wieling, W .
EUROPACE, 2004, 6 (06) :467-537
[4]   Proposed electrocardiographic classification of spontaneous syncope documented by an implantable loop recorder [J].
Brignole, M ;
Moya, A ;
Menozzi, C ;
Garcia-Civera, R ;
Sutton, R .
EUROPACE, 2005, 7 (01) :14-18
[5]   International Study on Syncope of Uncertain Etiology 2: the management of patients with suspected or certain neurally mediated syncope after the initial evaluation Rationale and study design [J].
Brignole, M ;
Sutton, R ;
Menozzi, C ;
Moya, A ;
Garcia-Civera, R ;
Benditt, D ;
Vardas, P ;
Wieling, W ;
Andresen, D ;
Migliorini, R ;
Hollinworth, D .
EUROPACE, 2003, 5 (03) :317-321
[6]   Guidelines on management (diagnosis and treatment) of syncope [J].
Brignole, M ;
Alboni, P ;
Benditt, D ;
Bergfeldt, L ;
Blanc, JJ ;
Thomsen, PEB ;
van Dijk, JG ;
Fitzpatrick, A ;
Hohnloser, S ;
Janousek, J ;
Kapoor, W ;
Kenny, RA ;
Kulakowski, P ;
Moya, A ;
Raviele, A ;
Sutton, R ;
Theodorakis, G ;
Wieling, W .
EUROPEAN HEART JOURNAL, 2001, 22 (15) :1256-1306
[7]  
Brignole M, 1997, CIRCULATION, V96, P3921
[8]   New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification - Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge [J].
Brignole, M ;
Menozzi, C ;
Del Rosso, A ;
Costa, S ;
Gaggioli, G ;
Bottoni, N ;
Bartoli, P ;
Sutton, R .
EUROPACE, 2000, 2 (01) :66-76
[9]   Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope - Second Vasovagal Pacemaker Study (VPS II): A randomized trial [J].
Connolly, SJ ;
Sheldon, R ;
Thorpe, KE ;
Roberts, RS ;
Ellenbogen, KA ;
Wilkoff, BL ;
Morillo, C ;
Gent, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (17) :2224-2229
[10]   An Implantable loop recorder study of highly symptomatic vasovagal patients - The heart rhythm observed during a spontaneous syncope is identical to the recurrent syncope but not correlated with the head-up tilt test or adenosine triphosphate test [J].
Deharo, JC ;
Jego, C ;
Lanteaume, A ;
Djiane, P .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (03) :587-593